Adverse events with oral ibandronate in women with postmenopausal osteoporosis (n=1602)

1
Adverse events with oral ibandronate in women
with postmenopausal osteoporosis (n1602)
Adverse event Once-monthly (150 mg) Once daily (25 mg)
Abdominal pain () 7.8 5.3
Hypertension () 6.3 7.3
Dyspepsia () 5.6 7.1
Arthralgia () 5.6 3.5
Nausea () 5.1 4.8
Diarrhea () 5.1 4.1
Recker R. American Society for Bone and Mineral
Research 2004 annual meeting October 1 - 5,
2004 Seattle, WA.
New once-monthly bisphosphonate for osteoporosis
Rheumawire gt News Mar 29, 2005